IRIS
CIRIONI, Oscar
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.576
EU - Europa 7.199
AS - Asia 6.925
SA - Sud America 1.486
AF - Africa 387
Continente sconosciuto - Info sul continente non disponibili 355
OC - Oceania 19
Totale 31.947
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.258
SG - Singapore 2.347
VN - Vietnam 1.379
RU - Federazione Russa 1.253
UA - Ucraina 1.207
BR - Brasile 1.130
CN - Cina 1.090
IT - Italia 929
DE - Germania 677
IE - Irlanda 677
SE - Svezia 662
TR - Turchia 585
HK - Hong Kong 572
FR - Francia 467
DK - Danimarca 433
FI - Finlandia 349
GB - Regno Unito 253
KR - Corea 245
CI - Costa d'Avorio 192
IN - India 145
CA - Canada 133
AR - Argentina 125
BD - Bangladesh 117
MX - Messico 104
NL - Olanda 66
EC - Ecuador 63
JP - Giappone 61
ZA - Sudafrica 58
IQ - Iraq 54
CO - Colombia 49
ID - Indonesia 49
PL - Polonia 47
PK - Pakistan 41
MA - Marocco 40
VE - Venezuela 36
UZ - Uzbekistan 35
AT - Austria 32
PH - Filippine 30
ES - Italia 29
PY - Paraguay 28
IR - Iran 27
BE - Belgio 25
PE - Perù 20
CL - Cile 18
EG - Egitto 18
MY - Malesia 18
TN - Tunisia 18
CR - Costa Rica 14
LT - Lituania 14
RO - Romania 14
JO - Giordania 13
KE - Kenya 13
KZ - Kazakistan 13
SA - Arabia Saudita 12
AE - Emirati Arabi Uniti 11
AU - Australia 11
JM - Giamaica 10
NP - Nepal 10
OM - Oman 10
UY - Uruguay 10
BG - Bulgaria 9
DO - Repubblica Dominicana 9
DZ - Algeria 9
ET - Etiopia 9
PS - Palestinian Territory 9
TH - Thailandia 9
TT - Trinidad e Tobago 9
EU - Europa 8
IL - Israele 8
AZ - Azerbaigian 7
HR - Croazia 7
PA - Panama 7
CH - Svizzera 6
PR - Porto Rico 6
RS - Serbia 6
AL - Albania 5
BO - Bolivia 5
CY - Cipro 5
HN - Honduras 5
NI - Nicaragua 5
SN - Senegal 5
CG - Congo 4
GR - Grecia 4
GT - Guatemala 4
LY - Libia 4
MD - Moldavia 4
NG - Nigeria 4
PT - Portogallo 4
SV - El Salvador 4
TW - Taiwan 4
AO - Angola 3
BH - Bahrain 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
HU - Ungheria 3
KW - Kuwait 3
LB - Libano 3
MT - Malta 3
SY - Repubblica araba siriana 3
BB - Barbados 2
Totale 31.559
Salva come PNG Salva come JPEG
Città #
Ashburn 2.368
Singapore 1.415
Jacksonville 1.205
Chandler 1.045
Dallas 853
Fairfield 827
San Jose 730
Dublin 668
Council Bluffs 615
Boardman 614
Hong Kong 549
Wilmington 489
Ho Chi Minh City 450
Woodbridge 401
New York 377
Hanoi 351
Seattle 323
Houston 317
Beijing 291
Ann Arbor 266
Des Moines 265
Moscow 261
Princeton 255
Lawrence 253
Cambridge 250
San Mateo 246
Los Angeles 234
Lauterbourg 220
The Dalles 216
Abidjan 192
Hefei 168
Munich 120
San Diego 118
Turin 114
Buffalo 102
São Paulo 99
Milan 94
Centro 83
Santa Clara 76
Da Nang 75
Orem 67
Helsinki 63
Phoenix 61
Turku 61
London 57
Chicago 54
Redmond 48
Tokyo 46
Haiphong 43
Montreal 43
Guangzhou 41
Shanghai 41
Warsaw 39
Chennai 38
Miano 35
Tashkent 34
Washington 34
Ancona 33
Atlanta 33
Mexico City 33
Rio de Janeiro 33
Denver 32
Columbus 30
Izmir 29
Johannesburg 29
Nuremberg 29
Rome 29
Norwalk 28
Brooklyn 27
Brasília 24
Brussels 24
Manchester 24
Mumbai 23
Wuhan 23
Falls Church 22
Hải Dương 22
Amsterdam 21
San Francisco 21
Belo Horizonte 20
Guayaquil 20
Marche 20
Poplar 20
Porto 20
Biên Hòa 19
Boston 18
Stockholm 18
Dhaka 17
Ottawa 17
Vienna 17
Baghdad 16
Bắc Ninh 16
Can Tho 16
Curitiba 16
Frankfurt am Main 16
New Delhi 16
Salt Lake City 16
Buenos Aires 15
Campinas 15
Caracas 15
Kilburn 15
Totale 19.347
Salva come PNG Salva come JPEG
Nome #
Supplementation with tocotrienols from Bixa orellana improves the in vivo efficacy of daptomycin against methicillin-resistant Staphylococcus aureus in a mouse model of infected wound 443
Comparative efficacy of topical versus systemic teicoplanin in experimental model of wound infections 335
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 269
RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 233
Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture. 215
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. 210
Anticryptosporidial activity of paromomycin. 204
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 203
Enhanced efficacy of combinations of pexiganan with colistin versus Acinetobacter baumannii in experimental sepsis 200
Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture. 196
Characterization of a new transferable MDR plasmid carrying the pbp5 gene from a clade B commensal Enterococcus faecium 191
Characterization of a Multiresistance Plasmid Carrying the optrA and cfr Resistance Genes From an Enterococcus faecium Clinical Isolate 189
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 188
Characterization and clonal diffusion of ceftaroline non-susceptible mrsa in two hospitals in central Italy 188
Colistin enhances therapeutic efficacy of daptomycin or teicoplanin in a murine model of multiresistant Acinetobacter baumannii sepsis. 187
Antimicrobial activity of polycationic peptides 185
Late or missed HIV diagnosis during pregnancy is still occurring in a high-income country and represents a high risk of MTCT 184
Efficacy of the quorum sensing inhibitor FS10 alone and in combination with tigecycline in an animal model of staphylococcal infected wound 184
Tollerabilità metabolica e durevolezza degli schemi antiretrovirali comprendenti nevirapina (Durability and tolerability of long-term nevirapine-based HAART). 183
Ceftazidime-Avibactam for the Treatment of Multidrug-Resistant Pathogens: A Retrospective, Single Center Study 177
Antimicrobial properties of distinctin in an experimental model of MRSA-infected wounds. 173
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 166
Trend of clinical vancomycin-resistant enterococci isolated in a regional Italian hospital from 2001 to 2018 165
Antimicrobial activity of aztreonam in combination with old and new β-lactamase inhibitors against mbl and esbl co-producing gram-negative clinical isolates: Possible options for the treatment of complicated infections 164
Protective effects of the combination alpha-helical antimicrobial peptides and rifampin in three rat models of Pseudomonas aeruginosa infection 163
In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria. 163
Use of dalbavancin in skin, bone and joint infections: A real-life experience in an Italian center 162
Epidemiology and microbiology of surgical wound infections. 159
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 157
Effects of the Infusion of 4% or 20% Human Serum Albumin on the Skeletal Muscle Microcirculation in Endotoxemic Rats 154
Anticryptosporidial activity of ranalexin, lasalocid and azithromycin alone and in combination in cell lines. 154
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 153
Amphibian Peptides Prevent Endotoxemia and Bacterial Translocation in Bile Duct-Ligated Rats 153
[Giardiasis: a parasitic disease of continued topicality. Study of prevalence among a selected adult population] 152
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 152
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock 152
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 152
In-vitro effect of short-term exposure to two synthetic peptides, alone or in combination with clarithromycin or rifabutin, on Cryptosporidium parvum infectivity. 151
In vitro activity of Protegrin-1, alone and in combination with clinically useful antibiotics, against Acinetobacter baumannii strains isolated from surgical wounds 150
Spread of colistin resistance gene mcr-1 in Italy: characterization of the mcr-1.2 allelic variant in a colistin-resistant blood isolate of Escherichia coli 149
Daptomycin and Rifampin Alone and in Combination Prevent Vascular Graft Biofilm Formation and Emergence of Antibiotic Resistance in a Subcutaneous Rat Pouch Model of Staphylococcal Infection. 148
In vitro and in vivo activity of fosfomycin alone and in combination with rifampin and tigecycline against Grampositive cocci isolated from surgical wound infections 147
Tachyplesin III and Granulocyte-Colony Stimulating Factor Enhance the Efficacy of Piperacillin/Tazobactam in a Neutropenic Mouse Model of Polymicrobial Peritonitis 146
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 146
In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection. 145
A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci. 145
The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 144
Clinical and microbiological features of ceftolozane/tazobactam-resistant Pseudomonas aeruginosa isolates in a university hospital in central Italy 143
Efficacy of Tigecycline and Rifampin Alone and in Combination against Enterococcus faecalis Biofilm Infection in a Rat Model of Ureteral Stent. 143
Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance. 143
BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection 142
In-vitro activity of the synthetic protegrin IB-367 alone and in combination with antifungal agents against clinical isolates of Candida spp. 141
In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi. 141
Efficacy of pexiganan combination with tigecycline in a mouse model of Pseudomonas aeruginosa sepsis 141
Effect of omiganan on colonic anastomosis healing in a rat model of peritonitis 140
High rate of ceftobiprole resistance among clinical methicillin-resistant Staphylococcus aureus isolates from a hospital in central Italy 139
Antimicrobial peptides (Temporin A and Iseganan IB-367): effect on the cysticerci of Taenia crassiceps. 138
In vitro and in vivo effects of sub-MICs of pexiganan and imipenem on Pseudomonas aeruginosa adhesion and biofilm development. 138
Animal models commonly used to study quorum-sensing inhibitors. 137
Role of daptomycin on burn wound healing in an animal methicillin-resistant staphylococcus aureus infection model 137
Efficacy of the amphibian peptide distinctin in a neutropenic mouse model of staphylococcal sepsis 136
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 136
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 136
Anticryptosporidial activity of cationic peptides alone and in combination with inhibitors of ion transport systems. 136
Review: A safety profile of dalbavancin for onand off-label utilization 135
ER-mitochondria association negatively affects wound healing by regulating NLRP3 activation 134
In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection. 134
whISOBAX™ inhibits bacterial pathogenesis and enhances the effect of antibiotics 134
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 133
In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients. 133
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 133
In vitro activity and killing effect of citropin 1.1 against gram-positive pathogens causing skin and soft tissue infections. 132
In vitro activities of tritrpticin alone and in combination with other antimicrobial agents against Pseudomonas aeruginosa. 132
Cationic peptides combined with betalactams reduce mortality from peritonitis in experimental rat model. 132
Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection. 131
[Vascular graft infection by Staphylococcus epidermidis: efficacy of various perioperative prophylaxis protocols in an animal model]. 130
Antiretroviral therapy management and rationalisation of available resources 129
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 128
Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis. 128
Antimicrobial Activity of Different Antimicrobial Peptides (AMPs) Against Clinical Methicillin-resistant Staphylococcus aureus (MRSA) 128
Safety and efficacy of vaccines during covid-19 pandemic in patients treated with biological drugs in a dermatological setting 128
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides. 127
IB-367 pre-treatment improves the in vivo efficacy of teicoplanin and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus 127
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock 127
The Antimicrobial Peptide Tachyplesin III Coated alone and in Combination with Intraperitoneal Piperacillin-Tazobactam Prevents Ureteral Stent Biofilm Formation in a Rat Subcutaneous Pouch Model of Pseudomonas Infection. 125
Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides. 125
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. 125
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model. 125
A In vitro and in vivo activity of aurintricarboxylic acid against Cryptosporidium parvum 125
Rate and determinants of residual viremia in multidrug-experienced patients successfully treated with raltegravir-based regimens 125
RNAIII-Inhibiting Peptide-Loaded Polymethylmethacrylate Prevents In Vivo Staphylococcus aureus Biofilm Formation 124
Comparative activities of cecropin A, melittin, and cecropin A-melittin peptide CA(1-7)M(2-9)NH2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii. 124
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 124
Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. 124
Delayed wound healing in aged skin rat models after thermal injury is associated with an increased MMP-9, K6 and CD44 expression 123
Methicillin-resistant Staphylococcus aureus as a cause of chronic wound infections: Alternative strategies for management 122
In vitro activity of the lipopeptide derivative (Pal-Lys-Lys-NH), alone and in combination with antifungal agents, against clinical isolates of dermatophytes. 122
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. 122
In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients. 122
Urinary catheters and biofilm formation 122
Totale 15.490
Salva come PNG Salva come JPEG
Categoria #
all - tutte 142.531
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 142.531
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.439 0 0 13 104 33 146 86 117 142 263 130 405
2022/20233.419 338 330 251 242 265 515 5 180 879 18 270 126
2023/20241.945 360 46 132 318 345 408 33 55 17 22 21 188
2024/20254.211 542 331 246 130 156 211 417 165 890 222 411 490
2025/202611.567 663 917 930 1.291 1.086 748 2.083 1.146 1.065 905 261 472
2026/20271.521 666 611 244 0 0 0 0 0 0 0 0 0
Totale 31.947